The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.
June 1st 2024
The addition of ribociclib (Kisqali; Novartis) to endocrine therapy demonstrated a 28% risk reduction in invasive disease-free survival.
Pregnancy Hormone Research May Lead to New Methods of Breast Cancer Prevention
October 7th 2014Researchers in Finland are learning more about how hormones influence the risk of developing breast cancer, which may lead to a hormone-based treatment to reduce the risk of developing cancer later in life.
Read More
In Breast Cancer, a Blood Test Could Determine the Next Stage of Therapy
June 25th 2014Researchers in the United Kingdom have identified a blood test for circulating free DNA that may help physicians predict whether or not a patient with breast cancer is likely to respond to an initial round of chemotherapy, enabling earlier initiation of alternate treatments.
Read More
Charles M. Perou, PhD, Discusses Genomic Signatures and Dual HER2-Targeting in Breast Cancer
June 17th 2014Charles M. Perou, PhD, professor of genetics, pathology & laboratory medicine, UNC Lineberger Comprehensive Cancer Center, discusses a trial (CALGB 40601) presented at the 2014 ASCO Annual Meeting.
Watch